Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy

Journal of Cardiac Failure

Volumn 16, Issue 12, 2010, Pages 931-937

  Bhattacharya, Sanjoy ^a   Abebe, Kaleab ^b   Simon, Marc ^a   Saba, Samir ^a   Adelstein, Evan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac resynchronization; Defibrillators; Heart failure; Inotropes

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEFIBRILLATOR; DRUG TOLERANCE; FEMALE; GENDER; GRAFT RECIPIENT; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOTONIC AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78649448776     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.07.253     Document Type: Article

References (21)

1. L.W. Stevenson Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy Circulation 108 2003 492 497
2. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, D.F. Heitjan, L.W. Stevenson, and W. Dembitsky Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
3. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
4. J.B. Young, W.T. Abraham, A.L. Smith, A.R. Leon, R. Lieberman, and B. Wilkoff Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694
5. S.L. Higgins, J.D. Hummel, I.K. Niazi, M.C. Giudici, S.J. Worley, and L.A. Saxon Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias J Am Coll Cardiol 42 2003 1454 1459
6. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. de Marco Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
7. J.G.F. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, and L. Tavazzi The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
8. B. Herweg, A. Ilercil, R. Cutro, R. Dewhurst, S. Krishnan, M. Weston, and S.S. Barold Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure Am J Cardiol 100 2007 90 93
9. K.B. James, M. Militello, B. Gus, and B.L. Wilkoff Biventricular Pacing for heart failure patients on inotropic support. A review of 38 consecutive cases Tex Heart Inst J 33 2006 19 22
10. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults J Am Coll Cardiol 53 2009 e1 e90
11. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A.M. Estes III, R.A. Freedman, and L.S. Gettes ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 2008 e1 e62
12. G.W. Imbens The role of the propensity score in estimating dose-response functions Biometrika 87 2000 706 710
13. M. Spreeuwenberg, A. Bartak, M.A. Croon, J.A. Hagenaars, J.J.V. Busschbach, and H. Andrea The Multiple Propensity Score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health Med Care 48 2010 166 174
14. P. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
15. Y. Konstantino, Z. Iakobishvili, O. Arad, T. Beg-Gal, J. Kusniec, and A. Mazur Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series Cardiology 106 2006 59 62
16. P.J. Cowburn, H. Patel, R.E. Jolliffe, R.W. Wald, and J.D. Parker Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure? Eur J Heart Fail 7 2005 215 217
17. 123I-MIBG scitigraphic study J Nucl Med 41 2000 845 851
18. H. Kawai, T.-H. Fan, E. Dong, R.A. Siddiqui, A. Yatani, S.Y. Stevens, and C.-S. Liand ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure Am J Physiol 277 1999 H1609 H1617
19. I.S. Anand, L.D. Fisher, Y.-T. Chiang, R. Latini, S. Masson, and A.P. Maggioni Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1278 1283
20. G. Boriani, F. Regoli, D. Saporito, C. Martignani, T. Toselli, and M. Biffi Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response Peptides 27 2006 1776 1786
21. A. Erol-Yilmaz, H.J. Verberne, T.A. Schrama, J. Hrudova, R.J. de Winter, and B.L.F. van Eck-Smit Cardiac resynchronization induces favorable neurohumoral changes PACE 28 2005 304 310